The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo
Open accessAbstract
arachidonic acid gas chromatography mass spectrometry prostaglandin isoprostanes polyunsaturated fatty acids eicosapentaenoic acid docosahexaenoic acid solid phase extraction cyclooxygenase liquid chromatography enzyme immunoassay radioimmunoassay low density lipoprotein thromboxane A2 receptor thromboxane The formation of prostaglandin-like structures as a product of arachidonic acid (AA)1 peroxidation in vitro was first reported by Mihelich and others (1Mihelich E.D. J. Am. Chem. Soc. 1980; 102: 7141-7143Crossref Scopus (68) Google Scholar, 2O'Connor D.E. Mihelich E.D. Coleman M.C. J. Am. Chem. Soc. 1981; 103: 223-224Crossref Scopus (62) Google Scholar, 3Nugteren D.H. Vonkeman H. Van Dorp D.A. Recl. Trav. Chim. Pays-Bas Belg. 1967; 86: 1237-1245Crossref Scopus (108) Google Scholar, 4Porter N.A. Funk M.O. J. Org. Chem. 1975; 40: 3614-3615Crossref PubMed Scopus (114) Google Scholar). However, it was Morrow, Roberts, and co-workers (5Wendelborn D.F. Seibert K. Roberts L.J., II Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 304-308Crossref PubMed Scopus (38) Google Scholar, 6Morrow J.D. Awad J.A. Boss H.J. Blair I.A. Roberts L.J., II Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 10721-10725Crossref PubMed Scopus (672) Google Scholar) who characterized interfering peaks observed in a GC/MS assay for 9α,11β-PGF2α, a metabolite of PGD2 in urine, as isomers of PGF2α. These compounds, termed F2-isoprostanes (F2-iPs), possess a 1,3-dihydroxycyclopentane ring (PGF ring) with hydroxyls mainly in the syn configuration and are formed from arachidonic acid by a free radical mechanism (5Wendelborn D.F. Seibert K. Roberts L.J., II Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 304-308Crossref PubMed Scopus (38) Google Scholar). Depending upon which of the labile hydrogen atoms is first abstracted by free radical attack, up to 64 isomers in four structural classes can be generated (6Morrow J.D. Awad J.A. Boss H.J. Blair I.A. Roberts L.J., II Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 10721-10725Crossref PubMed Scopus (672) Google Scholar). Compounds analogous to the F2-iPs may be formed from other fatty acid substrates (7Nourooz-Zadeh J. Halliwell B. Anggard E.E. Biochem. Biophys. Res. Commun. 1997; 236: 467-472Crossref PubMed Scopus (87) Google Scholar,8Roberts L.J., II Montine T.J. Markesbery W.R. Tapper A.R. Hardy P. Chemtob S. Dettbarn W.D. Morrow J.D. J. Biol. Chem. 1998; 273: 13605-13612Abstract Full Text Full Text PDF PubMed Scopus (376) Google Scholar). Similarly, free radical-derived isomers of other prostaglandins, leukotrienes, and epoxyeicosatrienoic acids have been reported (9Morrow J.D. Minton T.A. Mukundan C.R. Campbell M.D. Zackert W.E. Daniel V.C. Badr K.F. Blair I.A. Roberts L.J., II J. Biol. Chem. 1994; 269: 4317-4326Abstract Full Text PDF PubMed Google Scholar, 10Morrow J.D. Awad J.A. Wu A. Zackert W.E. Daniel V.C. Roberts L.J., II J. Biol. Chem. 1996; 271: 23185-23190Abstract Full Text Full Text PDF PubMed Scopus (107) Google Scholar, 11Harrison K.A. Murphy R.C. J. Biol. Chem. 1995; 270: 17273-17278Abstract Full Text Full Text PDF PubMed Scopus (99) Google Scholar, 12Mallat Z. Nakamura T. Ohan J. Lesecher G. Tecgui A. Maclouf J. Murphy R.C. J. Clin. Invest. 1999; 103: 421-427Crossref PubMed Scopus (165) Google Scholar). A new classification system for isoprostanes, based on the ω system of counting PUFA double bonds (13Rokach J. Khanapure S.P. Hwang S-W. Adiyaman M. Lawson J.A. FitzGerald G.A. Prostaglandins. 1997; 54: 853-873Crossref PubMed Scopus (130) Google Scholar), accounts for variations in chain length and the position of double bonds (Fig.1). PUFA, with a higher and a lower number of skipped double bonds than AA, can also be accommodated by this system (13Rokach J. Khanapure S.P. Hwang S-W. Adiyaman M. Lawson J.A. FitzGerald G.A. Prostaglandins. 1997; 54: 853-873Crossref PubMed Scopus (130) Google Scholar, 14Rokach J. Khanapure S.P. Hwang S-W. Adiyaman M. Schio L. FitzGerald G.A. Synthesis. 1998; 1: 569-580Crossref Scopus (54) Google Scholar). Selection of the ω system of counting the double bonds is designed to mimic the biochemical system by which the PUFA double bonds are generated at ω3, ω6, ω9, etc., ω being the terminal carbon of the PUFA. All ω3 PUFAs lead to iPs with identical lower side chains. Differences in chain length and the number of double bonds (n) in the original PUFA are reflected only in the upper side chains. For example, the iPs derived from EPA (an ω3 n-5 PUFA) and DHA (an ω3 n-6 PUFA), a major PUFA in the brain, have their lower side chains identical. The extra double bond in DHA leads to an additional two classes of iPs, Type VII and Type VIII. Alternatively, linolenic acid is a C18 ω3 n-3 PUFA with double bonds at ω3, ω6, and ω9. It can give rise to two classes of iPs, namely I and II, with lower side chains identical to Class I and Class II iPs from EPA and DHA. The upper side chains of these linolenic acid-derived iPs will have two carbons less than EPA and four carbons less than
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Low Density Lipoprotein Oxidation and Its Pathobiological Significance
Steinberg, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20963 · Cited by 1,642
Morrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W. E., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,339
Davı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.224 · Cited by 742
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
Morrow, J. D., Awad, J. A., Boss, H. J., Blair, I. A., & Roberts, L. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10721 · Cited by 735
Modulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers
Reilly, M., Delanty, N., Lawson, J. A., & FitzGerald, G. A. (1996) · Circulation · doi:10.1161/01.cir.94.1.19 · Cited by 612
Self-citationTakahashi, K., Nammour, T. M., Fukunaga, M., Ebert, J., Morrow, J. D., Roberts, L. J., Hoover, R. L., & Badr, K. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115826 · Cited by 511
Praticò, D., Tangirala, R. K., Rader, D. J., Rokach, J., & FitzGerald, G. A. (1998) · Nature Medicine · doi:10.1038/2685 · Cited by 501
Self-citationMorrow, J. D., Harris, T. M., & Jackson Roberts, L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90002-q · Cited by 477
Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., & Tedgui, A. (1998) · Circulation · doi:10.1161/01.cir.97.16.1536 · Cited by 453
Fitzgerald, D. J., Catella, F., Roy, L., & FitzGerald, G. A. (1988) · Circulation · doi:10.1161/01.cir.77.1.142 · Cited by 433
Self-citationFormation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid
Roberts, L. J., Montine, T. J., Markesbery, W. R., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W. D., & Morrow, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13605 · Cited by 418
Increased F 2 ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo
Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405
Self-citationNowak, J., Murray, J. J., Oates, J. A., & FitzGerald, G. A. (1987) · Circulation · doi:10.1161/01.cir.76.1.6 · Cited by 382
Self-citationLocalization of distinct F2-isoprostanes in human atherosclerotic lesions.
Praticò, D., Iuliano, L., Mauriello, A., Spagnoli, L., Lawson, J. A., Rokach, J., Maclouf, J., Violi, F., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119735 · Cited by 344
Self-citationImmunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
Wang, Z., Ciabattoni, G., Créminon, C., Lawson, J., Fitzgerald, G. A., Patrono, C., & Maclouf, J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12087-9 · Cited by 341
Self-citationMorrow, J. D., Minton, T. A., Mukundan, C. R., Campbell, M. D., Zackert, W. E., Daniel, V. C., Badr, K. F., Blair, I. A., & Roberts, L. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41781-9 · Cited by 299
Increased Formation of Distinct F2Isoprostanes in Hypercholesterolemia
Reilly, M. P., Praticò, D., Delanty, N., DiMinno, G., Tremoli, E., Rader, D., Kapoor, S., Rokach, J., Lawson, J., & FitzGerald, G. A. (1998) · Circulation · doi:10.1161/01.cir.98.25.2822 · Cited by 271
Self-citationDelanty, N., Reilly, M. P., Pratico, D., Lawson, J. A., McCarthy, J. F., Wood, A. E., Ohnishi, S. T., Fitzgerald, D. J., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.95.11.2492 · Cited by 267
Self-citation8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases
MONTUSCHI, P., TONI, G. C., PAREDI, P., PANTELIDIS, P., du BOIS, R. M., KHARITONOV, S. A., & BARNES, P. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9803102 · Cited by 267
Cylooxygenase-dependent Formation of the Isoprostane, 8-Epi Prostaglandin F2α
Pratico, D., Lawson, J. A., & FitzGerald, G. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9800 · Cited by 264
Self-citationPRATICÒ, D., BASILI, S., VIERI, M., CORDOVA, C., VIOLI, F., & FITZGERALD, G. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9709066 · Cited by 255
Self-citationCerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease
Montine, T. J., Markesbery, W. R., Morrow, J. D., & Roberts, L. J. (1998) · Annals of Neurology · doi:10.1002/ana.410440322 · Cited by 239
Lynch, S. M., Morrow, J. D., Roberts, L. J., & Frei, B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117107 · Cited by 236
IPF 2α -I: An index of lipid peroxidation in humans
Praticò, D., Barry, O. P., Lawson, J. A., Adiyaman, M., Hwang, S.-W., Khanapure, S. P., Iuliano, L., Rokach, J., & FitzGerald, G. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3449 · Cited by 219
Self-citationMorrow, J. D., Minton, T. A., & Roberts, L. J. (1992) · Prostaglandins · doi:10.1016/0090-6980(92)90077-7 · Cited by 215
Reilly, M. P., Delanty, N., Roy, L., Rokach, J., Callaghan, P. O., Crean, P., Lawson, J. A., & FitzGerald, G. A. (1997) · Circulation · doi:10.1161/01.cir.96.10.3314 · Cited by 210
Self-citationPraticò, D., Smyth, E. M., Violi, F., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14916 · Cited by 204
Self-citationGniwotta, C., Morrow, J. D., Roberts, L. J., & Kühn, H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.3236 · Cited by 196
Generation of 8-Epiprostaglandin F by Human Monocytes
Praticó, D., & FitzGerald, G. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8919 · Cited by 187
Self-citationFitzgerald, D. J., & Fitzgerald, G. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7585 · Cited by 177
Self-citationMallat, Z., Nakamura, T., Ohan, J., Lesèche, G., Tedgui, A., Maclouf, J., & Murphy, R. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3985 · Cited by 172
Roberts, L. J., Moore, K. P., Zackert, W. E., Oates, J. A., & Morrow, J. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20617 · Cited by 156
Nomenclature of Isoprostanes: A Proposal
Rokach, J., KHANAPURE, S. P., Hwang, S., Adiyaman, M., Lawson, J. A., & FitzGerald, G. A. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00184-6 · Cited by 144
Self-citationMetabolism of 8‐iso‐prostaglandin F2α
Basu, S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00481-5 · Cited by 126
Non‐enzymic conversion of all‐cis 8,11,14‐eicosatrienoic acid into prostaglandin E1
Nugteren, D. H., Vonkeman, H. E., & van Dorp, D. A. (1967) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19670861109 · Cited by 121
Kunapuli, P., Lawson, J. A., Rokach, J., Meinkoth, J. L., & FitzGerald, G. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22442 · Cited by 119
Self-citationMorrow, J. D., Awad, J. A., Wu, A., Zackert, W. E., Daniel, V. C., & Roberts, L. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23185 · Cited by 117
Bachi, A., Zuccato, E., Baraldi, M., Fanelli, R., & Chiabrando, C. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02087-x · Cited by 114
The Isoprostanes: A Perspective
Rokach, J., KHANAPURE, S. P., Hwang, S., Adiyaman, M., Lawson, J. A., & FitzGerald, G. A. (1997) · Prostaglandins · doi:10.1016/s0090-6980(97)00183-4 · Cited by 110
Self-citationIncreased circulating products of lipid peroxidation in patients with alcoholic liver disease.
Aleynik, S., Leo, M., Aleynik, M. K., & Lieber, C. S. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03637.x · Cited by 110
Protein kinase A phosphorylation enhances sodium channel currents in Xenopus oocytes
Smith, R. D., & Goldin, A. L. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.263.3.c660 · Cited by 108
Molecular and Cellular Basis of Inflammation
(1999) · Humana Press eBooks · doi:10.1007/978-1-59259-253-1 · Cited by 102
Isoleukotrienes are biologically active free radical products of lipid peroxidation
Harrison, K. A., & Murphy, R. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17273 · Cited by 98
Evidence for the Formation of F3-Isoprostanes during Peroxidation of Eicosapentaenoic Acid
Nourooz‐Zadeh, J., Halliwell, B. B., & Änggård, E. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6869 · Cited by 95
Identification and Measurement of Endogenous β-Oxidation Metabolites of 8-epi-Prostaglandin F2α
Chiabrando, C., Valagussa, A., Rivalta, C., Durand, T., Guy, A., Zuccato, E., Villa, P., Rossi, J., & Fanelli, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1313 · Cited by 95
Increased circulating products of lipid peroxidation in patients with alcoholic liver disease.
Aleynik, S. I., Leo, M. A., Aleynik, M. K., & Lieber, C. S. (1998) · PubMed · Cited by 93
Lawson, J. A., Li, H., Rokach, J., Adiyaman, M., Hwang, S., Khanapure, S. P., & FitzGerald, G. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29295 · Cited by 82
Self-citationPatrignani, P., Santini, G., Panara, M. R., Sciulli, M. G., Greco, A., Rotondo, M. T., di Giamberardino, M., Maclouf, J., Ciabattoni, G., & Patrono, C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15535.x · Cited by 75
Isolation and characterization of bicycloendoperoxides derived from methyl linolenate
O'Connor, D. E., Mihelich, E. D., & Coleman, M. C. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00391a056 · Cited by 72
Yin, K., Halushka, P. V., Yan, Y. T., & Wong, P. Y. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22527-7 · Cited by 67
Gopaul, N. K., Nourooz‐Zadeh, J., Mallet, A. I., & Änggård, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00628-8 · Cited by 63
Waugh, R. J., & Murphy, R. C. (1996) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(95)00709-1 · Cited by 62
Formation of PGF2-Isoprostanes During the Oxidative Modification of Low Density Lipoprotein
Gopaul, N. K., Nourooz‐Zadeh, J., Mallet, A. I., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1453 · Cited by 57
Using Natural Isotope Variations of Nitrogen in Plants as an Early Indicator of Air Pollution Stress
Hofmann, D., Jung, K., Bender, J., Gehre, M., & Schüürmann, G. (1997) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(199708)32:8<888::aid-jms548>3.0.co;2-w · Cited by 55
Total synthesis of a novel isoprostane IPF2α-I and its identification in biological fluids
Adiyaman, M., Lawson, J. A., Hwang, S., Khanapure, S. P., FitzGerald, G. A., & Rokach, J. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(96)00973-2 · Cited by 55
Self-citationRapid18O analysis of CO2 samples by continuous-flow isotope ratio mass spectrometry
Schoeller, D. A., & Luke, A. H. (1997) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(199712)32:12<1362::aid-jms606>3.0.co;2-n · Cited by 46
Diels−Alder Approach to Isoprostanes. Total Synthesis of iPF2α-V
Pudukulathan, Z. K., Manna, S., Hwang, S., Khanapure, S. P., Lawson, J. A., FitzGerald, G. A., & Rokach, J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja982596k · Cited by 44
Self-citationTo E or Not To E—How Do We Tell?
Witztum, J. L. (1998) · Circulation · doi:10.1161/01.cir.98.25.2785 · Cited by 37
Wendelborn, D., Seibert, K., & Roberts, L. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.304 · Cited by 36
State of the art: Atherosclerosis in a limited edition
Rader, D. J., & FitzGerald, G. A. (1998) · Nature Medicine · doi:10.1038/nm0898-899 · Cited by 27
Self-citation
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
Powers, S. K., & Jackson, M. J. (2008) · Physiological Reviews · doi:10.1152/physrev.00031.2007 · Cited by 2,459
Halliwell, B., & Whiteman, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705776 · Cited by 2,238
Free Radical Lipid Peroxidation: Mechanisms and Analysis
Yin, H., Xu, L., & Porter, N. A. (2011) · Chemical Reviews · doi:10.1021/cr200084z · Cited by 1,937
Marnett, L. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.361 · Cited by 1,883
Metadata
- Authors
- Lawson, J. A., FitzGerald, G. A., & Rokach, J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-08
- Volume
- 274
- Issue
- 35
- Pages
- 24441-24444
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1975419167
- Cited by
- 381
- References
- 60
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.